Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 7
2020 6
2021 5
2022 6
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Long-term nutrition alterations after surgery for gastrointestinal cancers.
Jacobson R, Gurd EN, Pimiento JM. Jacobson R, et al. Nutr Clin Pract. 2023 Aug;38(4):721-730. doi: 10.1002/ncp.11035. Epub 2023 Jun 11. Nutr Clin Pract. 2023. PMID: 37302063 Review.
This review is intended for multidisciplinary teams to better understand the postoperative anatomy, physiology, and nutrition morbidity of GI cancer operations. We have arranged this paper by the anatomic and functional changes to the GI tract intrinsic to common cancer …
This review is intended for multidisciplinary teams to better understand the postoperative anatomy, physiology, and nutrition morbidity of G …
Efficient gradient boosting for prognostic biomarker discovery.
Li K, Yao S, Zhang Z, Cao B, Wilson CM, Kalos D, Kuan PF, Zhu R, Wang X. Li K, et al. Bioinformatics. 2022 Mar 4;38(6):1631-1638. doi: 10.1093/bioinformatics/btab869. Bioinformatics. 2022. PMID: 34978570 Free PMC article.
However, these modern techniques have not yet been widely adopted in discovering biomarkers for censored survival outcomes, which are key clinical outcomes or endpoints in cancer studies. RESULTS: In this paper, we present a new R package 'Xsurv' as an integrated solution …
However, these modern techniques have not yet been widely adopted in discovering biomarkers for censored survival outcomes, which are key cl …
Factors associated with self-reported social isolation among patients with cancer during the COVID-19 pandemic.
Hathaway CA, Bloomer AM, Oswald LB, Siegel EM, Peoples AR, Ulrich CM, Penedo FJ, Tworoger SS, Gonzalez BD. Hathaway CA, et al. Health Psychol. 2022 Apr;41(4):311-318. doi: 10.1037/hea0001172. Health Psychol. 2022. PMID: 35324248 Free PMC article.
METHOD: Moffitt Cancer Center patients seen on or after January 1, 2015, had a last known alive vital status, a valid e-mail address, and were 18-89 years old, were emailed a survey regarding social isolation. We collected information on age, sex, race, ethni …
METHOD: Moffitt Cancer Center patients seen on or after January 1, 2015, had a last known alive vital status, a valid e …
A survey of oncology advanced practice providers' knowledge and attitudes towards sexual and gender minorities with cancer.
Sutter ME, Bowman-Curci ML, Duarte Arevalo LF, Sutton SK, Quinn GP, Schabath MB. Sutter ME, et al. J Clin Nurs. 2020 Aug;29(15-16):2953-2966. doi: 10.1111/jocn.15302. Epub 2020 May 11. J Clin Nurs. 2020. PMID: 32320511 Free PMC article.
BACKGROUND: SGM individuals experience health disparities, in part due to lack of access to knowledgeable providers. Despite the important role of APPs in cancer care, less is known about their attitudes and knowledge towards SGM cancer patients. DESIGN: Cross-secti …
BACKGROUND: SGM individuals experience health disparities, in part due to lack of access to knowledgeable providers. Despite the important r …
Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplantation Survivors.
Hong S, Zhao J, Wang S, Wang H, Lee JH, Farhadfar N, McGuirk JP, Savani BN, Shahrukh HK, Stiff P, Khera N, Hahn T, Loren AW, Jaglowski SM, Wood WA, Saber W, Cerny J, Holtan SG, Reynolds JM, Deol A, Jim H, Uberti J, Whalen V, Yi JC, Preussler J, Baker KS, Shaw BE, Devine S, Syrjala K, Majhail NS, Wingard JR, Al-Mansour Z. Hong S, et al. Transplant Cell Ther. 2023 Mar;29(3):202.e1-202.e8. doi: 10.1016/j.jtct.2022.11.016. Epub 2022 Nov 23. Transplant Cell Ther. 2023. PMID: 36427784 Free PMC article.
In this secondary analysis using data from 2 randomized controlled trials, we analyzed baseline Cancer and Treatment Distress (CTXD) and Confidence In Survivorship Information (CSI) surveys of HCT survivors who were age 60 years at the time of transplantation and alive and …
In this secondary analysis using data from 2 randomized controlled trials, we analyzed baseline Cancer and Treatment Distress (CTXD) …
A mixed-methods study of cyclin-dependent kinase 4 and 6 inhibitor symptom burden and quality of life among metastatic breast cancer patients and providers.
Oswald LB, Arredondo B, Kadono M, Martinez-Tyson D, Meade CD, Penedo F, Antoni MH, Soliman H, Costa RLB, Jim HSL. Oswald LB, et al. Cancer Med. 2021 Jul;10(14):4823-4831. doi: 10.1002/cam4.4055. Epub 2021 Jun 24. Cancer Med. 2021. PMID: 34165265 Free PMC article.
BACKGROUND: Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor targeted therapies dramatically improve survival outcomes for metastatic breast cancer (MBC), but they are associated with significant symptom burden that can impact patients' health-related quality of life (HR …
BACKGROUND: Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor targeted therapies dramatically improve survival outcomes for metastatic brea …
Qualitative assessment of knowledge and attitudes towards cervical cancer screening among male Latino immigrants in Houston, Texas.
Read SH, Valverde I, Montealegre JR, Rutherford TJ, Anderson ML. Read SH, et al. BMC Womens Health. 2020 Jul 6;20(1):141. doi: 10.1186/s12905-020-01006-5. BMC Womens Health. 2020. PMID: 32631299 Free PMC article.
BACKGROUND: Male spouses and partners play an important role in determining a woman's willingness to participate in cervical cancer screening. However, the attitudes and behaviors by which they influence a woman's decision to undergo Pap testing remain poorly understood. . …
BACKGROUND: Male spouses and partners play an important role in determining a woman's willingness to participate in cervical cancer s …
Promoterless Transposon Mutagenesis Drives Solid Cancers via Tumor Suppressor Inactivation.
Aiderus A, Contreras-Sandoval AM, Meshey AL, Newberg JY, Ward JM, Swing DA, Copeland NG, Jenkins NA, Mann KM, Mann MB. Aiderus A, et al. Cancers (Basel). 2021 Jan 9;13(2):225. doi: 10.3390/cancers13020225. Cancers (Basel). 2021. PMID: 33435458 Free PMC article.
A central challenge in cancer genomics is the systematic identification of single and cooperating tumor suppressor gene mutations driving cellular transformation and tumor progression in the absence of oncogenic driver mutation(s). ...We provide a quantitative landscape of …
A central challenge in cancer genomics is the systematic identification of single and cooperating tumor suppressor gene mutations dri …
Factors associated with prior completion of colorectal cancer and hepatitis C virus screenings among community health center patients: a cross-sectional study to inform a multi-behavioral educational intervention.
Gutstein L, Arevalo M, Reich RR, Fan W, Vadaparampil ST, Meade CD, Abdulla R, Lawrence E, Roetzheim RG, Lopez D, Collier A, Deak E, Ewing AP, Gwede CK, Christy SM. Gutstein L, et al. J Behav Med. 2024 Apr;47(2):295-307. doi: 10.1007/s10865-023-00460-4. Epub 2023 Dec 21. J Behav Med. 2024. PMID: 38127175
BACKGROUND: Colorectal cancer (CRC) and liver cancer are two of the leading causes of cancer death in the United States and persistent disparities in CRC and liver cancer incidence and outcomes exist. Chronic hepatitis C virus (HCV) infection is one of …
BACKGROUND: Colorectal cancer (CRC) and liver cancer are two of the leading causes of cancer death in the United States …
Toxoplasma gondii infection and the risk of adult glioma in two prospective studies.
Hodge JM, Coghill AE, Kim Y, Bender N, Smith-Warner SA, Gapstur S, Teras LR, Grimsrud TK, Waterboer T, Egan KM. Hodge JM, et al. Int J Cancer. 2021 May 15;148(10):2449-2456. doi: 10.1002/ijc.33443. Epub 2021 Jan 11. Int J Cancer. 2021. PMID: 33427315 Free article.
Therefore, we examined the association between prediagnostic T gondii antibodies and risk of glioma in two prospective cohorts using a nested case-control study design. Cases and matched controls were selected from the American Cancer Society's Cancer Prevention Stu …
Therefore, we examined the association between prediagnostic T gondii antibodies and risk of glioma in two prospective cohorts using a neste …
28 results